• Je něco špatně v tomto záznamu ?

Risk factors of thrombosis in a cohort of 206 patients with BCR-ABL1 negative myeloproliferative neoplasms

MH. Aswad, J. Kissova, P. Ovesna, M. Penka

. 2021 ; 68 (6) : 1341-1350. [pub] 20211026

Jazyk angličtina Země Slovensko

Typ dokumentu časopisecké články

Perzistentní odkaz   https://www.medvik.cz/link/bmc22003352

Thrombosis is the most common complication in BCR-ABL1 negative myeloproliferative neoplasms (MPN) that significantly impacts patients' mortality. Generally, there is an agreement on risk factors that possibly contribute to the increased risk of thrombosis, including age, history of thrombosis, JAK2V617F mutation, and cardiovascular risk factors. This study retrospectively investigates MPN-related and patient-related variables in relation to the thrombosis occurrence in MPN. Our analyses show that JAK2V617F-mutated patients are at a significantly increased risk of thrombosis within five years before the MPN diagnosis point with a hazard ratio (HR) of 15.49 (p=0.006). In multivariate analyses, independent risk factors for thrombotic complications during the follow-up are history of thrombosis (HR=2.23, p=0.019), age over 60 years at diagnosis (HR=1.56, p=0.037), the presence of JAK2V617F mutation (HR=3.01, p=0.002), and tobacco smoking (HR=1.75, p=0.01). Our results support the multifactorial mechanism of thrombosis in MPN patients, which demands individual and complex management.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc22003352
003      
CZ-PrNML
005      
20220127150319.0
007      
ta
008      
220113s2021 xo f 000 0|eng||
009      
AR
024    7_
$a 10.4149/neo_2021_210729N1068 $2 doi
035    __
$a (PubMed)34704452
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xo
100    1_
$a Aswad, Mohamed Hussam $u Department of Clinical Hematology, University Hospital Brno, Masaryk University, Brno, Czech Republic $u Faculty of Medicine, Masaryk University, Brno, Czech Republic
245    10
$a Risk factors of thrombosis in a cohort of 206 patients with BCR-ABL1 negative myeloproliferative neoplasms / $c MH. Aswad, J. Kissova, P. Ovesna, M. Penka
520    9_
$a Thrombosis is the most common complication in BCR-ABL1 negative myeloproliferative neoplasms (MPN) that significantly impacts patients' mortality. Generally, there is an agreement on risk factors that possibly contribute to the increased risk of thrombosis, including age, history of thrombosis, JAK2V617F mutation, and cardiovascular risk factors. This study retrospectively investigates MPN-related and patient-related variables in relation to the thrombosis occurrence in MPN. Our analyses show that JAK2V617F-mutated patients are at a significantly increased risk of thrombosis within five years before the MPN diagnosis point with a hazard ratio (HR) of 15.49 (p=0.006). In multivariate analyses, independent risk factors for thrombotic complications during the follow-up are history of thrombosis (HR=2.23, p=0.019), age over 60 years at diagnosis (HR=1.56, p=0.037), the presence of JAK2V617F mutation (HR=3.01, p=0.002), and tobacco smoking (HR=1.75, p=0.01). Our results support the multifactorial mechanism of thrombosis in MPN patients, which demands individual and complex management.
650    _2
$a lidé $7 D006801
650    _2
$a Janus kinasa 2 $x genetika $7 D053614
650    _2
$a lidé středního věku $7 D008875
650    _2
$a mutace $7 D009154
650    12
$a nádory $7 D009369
650    _2
$a retrospektivní studie $7 D012189
650    _2
$a rizikové faktory $7 D012307
650    12
$a trombóza $x genetika $7 D013927
655    _2
$a časopisecké články $7 D016428
700    1_
$a Kissova, Jarmila $u Department of Clinical Hematology, University Hospital Brno, Masaryk University, Brno, Czech Republic $u Faculty of Medicine, Masaryk University, Brno, Czech Republic
700    1_
$a Ovesna, Petra $u Institute of Biostatistics and Analyses, Masaryk University, Brno, Czech Republic
700    1_
$a Penka, Miroslav $u Department of Clinical Hematology, University Hospital Brno, Masaryk University, Brno, Czech Republic $u Faculty of Medicine, Masaryk University, Brno, Czech Republic
773    0_
$w MED00003470 $t Neoplasma $x 0028-2685 $g Roč. 68, č. 6 (2021), s. 1341-1350
856    41
$u https://pubmed.ncbi.nlm.nih.gov/34704452 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y p $z 0
990    __
$a 20220113 $b ABA008
991    __
$a 20220127150316 $b ABA008
999    __
$a ok $b bmc $g 1750965 $s 1154501
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2021 $b 68 $c 6 $d 1341-1350 $e 20211026 $i 0028-2685 $m Neoplasma $n Neoplasma $x MED00003470
LZP    __
$a Pubmed-20220113

Najít záznam

Citační ukazatele

Možnosti archivace